Chitnis T, Arnold DL, Banwell B, et al. PARADIGMS: a randomised double-blind study of fingolimod versus interferon β-1a in paediatric multiple sclerosis. ECTRIMS 2017, #276.
Eerste patiënt in Nederland behandeld met tisagenlecleucel CAR T-celtherapie
jun 2019 | Leukemie